Cargando…
Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID‐19) patients: Is it really pancreatic injury?
Coronavirus disease 2019 (COVID‐19) is a novel disorder caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Although it mainly affects the respiratory system, the pancreas could also become the virus' target. The issue regarding pancreatic involvement in COVID‐19 has been ra...
Autores principales: | Pribadi, Rabbinu R, Simadibrata, Marcellus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857272/ https://www.ncbi.nlm.nih.gov/pubmed/33553654 http://dx.doi.org/10.1002/jgh3.12436 |
Ejemplares similares
-
Role of thigh circumference, calf circumference, subjective global assessment, and handgrip strength as diagnostic modalities of sarcopenia in women inflammatory bowel disease patients
por: Pribadi, Rabbinu Rangga, et al.
Publicado: (2022) -
COVID-19 and Serum Amylase and Lipase Levels
por: Prasad, Himanshu, et al.
Publicado: (2022) -
A systematic review and meta-analysis of the relationship between advanced glycation end products ceceptor (RAGE) gene polymorphisms and the risk of inflammatory bowel disease
por: Febrinasari, Ratih Puspita, et al.
Publicado: (2023) -
Serum amylase and lipase levels for prediction of postendoscopic retrograde cholangiopancreatography pancreatitis
por: Minakari, Mohammad, et al.
Publicado: (2018) -
The relative sensitivity of serum lipase versus amylase for radiological image-positive pancreatitis
por: Delaney, K, et al.
Publicado: (2007)